Table 4.
Periodontal pathogen | Pg positive by PCR, % of patients | Anti‐Pg outer membrane antibody levels, mean ± SD μg/ml | Anti‐RgpB at OD450, mean ± SD μg/ml | Anti‐Pi outer membrane antibody levels, mean ± SD μg/ml | Anti‐Fn outer membrane antibody levels, mean ± SD μg/ml |
---|---|---|---|---|---|
CCP‐2+ (n = 240) | 61 | 106 ± 90 | 0.3 ± 0.4 | 145 ± 76 | 111 ± 115 |
CCP‐2− (n = 44) | 61 | 96 ± 84 | 0.3 ± 0.5 | 146 ± 93 | 96 ± 74 |
P | 1.000b | 0.365c | 0.495c | 0.564c | 0.308c |
cFIBβ+ (n = 190) | 64 | 112 ± 93 | 0.4 ± 0.5 | 150 ± 79 | 113 ± 124 |
cFIBβ− (n = 97) | 56 | 94 ± 81 | 0.3 ± 0.5 | 137 ± 79 | 97 ± 72 |
P | 0.195 | 0.108c | 0.191c | 0.109c | 0.229c |
cVIM+ (n = 92) | 65 | 114 ± 101 | 0.3 ± 0.4 | 154 ± 85 | 120 ± 164 |
cVIM− (n = 195) | 60 | 102 ± 84 | 0.4 ± 0.5 | 142 ± 76 | 102 ± 70 |
P | 0.37 | 0.508c | 0.604c | 0.247c | 0.979c |
CEP‐1+ (n = 95) | 67 | 122 ± 98 | 0.4 ± 0.5 | 156 ± 81 | 122 ± 158 |
CEP‐1− (n = 192) | 59 | 98 ± 84 | 0.3 ± 0.5 | 141 ± 78 | 101 ± 73 |
P | 0.21 | 0.022c | 0.221c | 0.105c | 0.297c |
cTNC5+ (n = 145) | 67 | 118 ± 96 | 0.4 ± 0.4 | 160 ± 78 | 118 ± 135 |
cTNC5− (n = 142) | 56 | 93 ± 81 | 0.3 ± 0.5 | 131 ± 78 | 97 ± 73 |
P | 0.068 | 0.015 | 0.212c | 0.001 | 0.109c |
cCK13‐1+ (n = 69) | 68 | 120 ± 99 | 0.4 ± 0.4 | 161 ± 81 | 137 ± 183 |
cCK13‐1− (n = 218) | 60 | 101 ± 86 | 0.3 ± 0.5 | 141 ± 78 | 98 ± 69 |
P | 0.231 | 0.197c | 0.230c | 0.050c | 0.078c |
Except where indicated otherwise, chi‐square tests were used to compare frequency distributions of categorical variables. Pg = Porphyromonas gingivalis; PCR = polymerase chain reaction; anti‐RgpB = anti–R gingipain type B; anti‐Pi = anti–Prevotella intermedia; anti‐Fn = anti–Fusobacterium nucleatum; CCP‐2 = cyclic citrullinated peptide 2; cFIBβ = citrullinated fibrinogen β; cVIM = citrullinated vimentin; CEP‐1 = citrullinated α‐enolase peptide 1; cTNC5 = citrullinated tenascin‐C; cCK13‐1 = citrullinated cytokeratin 13–derived peptide 1.
By Fisher's exact test.
By t‐tests and Wilcoxon's rank sum test.